E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 3.522 EUR 3.04% Market Closed
Market Cap: 335.5m EUR
Have any thoughts about
Euroapi SAS?
Write Note

Euroapi SAS
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Euroapi SAS
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
E
Euroapi SAS
PAR:EAPI
Other Current Liabilities
€87.4m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sanofi SA
PAR:SAN
Other Current Liabilities
€13.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ipsen SA
PAR:IPN
Other Current Liabilities
€757.9m
CAGR 3-Years
23%
CAGR 5-Years
13%
CAGR 10-Years
15%
Vetoquinol SA
PAR:VETO
Other Current Liabilities
€9m
CAGR 3-Years
-7%
CAGR 5-Years
14%
CAGR 10-Years
7%
Virbac SA
PAR:VIRP
Other Current Liabilities
€128.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medincell SA
PAR:MEDCL
Other Current Liabilities
€5.3m
CAGR 3-Years
-1%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

Euroapi SAS
Glance View

Market Cap
335.5m EUR
Industry
Pharmaceuticals

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

EAPI Intrinsic Value
4.441 EUR
Undervaluation 21%
Intrinsic Value
Price
E

See Also

What is Euroapi SAS's Other Current Liabilities?
Other Current Liabilities
87.4m EUR

Based on the financial report for Dec 31, 2023, Euroapi SAS's Other Current Liabilities amounts to 87.4m EUR.

What is Euroapi SAS's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
-12%

Over the last year, the Other Current Liabilities growth was 21%. The average annual Other Current Liabilities growth rates for Euroapi SAS have been -12% over the past three years .

Back to Top